Gene · 8029
CUBN: cubilin
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CUBN: cubilin. Genes, record 8029. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/8029
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O60494 | Cubilin | 3,623 | 2 | Ensembl, GeneID, HGNC |
Source UniProt
Patents47
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026067851 A | 2026-04-21 | 319 | O60494 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 42528 | O60494 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 9972 | O60494 | Espacenet |
| EP 4640849 A2 | 2025-10-29 | 1509 | O60494 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 10236 | O60494 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 3772 | O60494 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 6067 | O60494 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 6067 | O60494 | Espacenet |
| JP 2025519096 A | 2025-06-24 | 1509 | O60494 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 10236 | O60494 | Espacenet |
1 to 10 of 47
See all 47 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,130
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CUBN papers | Newest fiscal year |
|---|---|---|---|
| P30CA016058 | Cancer Center Support Grant | 11 | 2025 |
| P30DK063491 | Diabetes Research Center (DRC) | 6 | 2025 |
| P01HL116263 | HDL Function in Human Disease | 4 | 2025 |
| ZIACP010195 | Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study | 4 | 2025 |
| P30CA062203 | Cancer Center Support Grant | 3 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 3 | 2025 |
| P30CA076292 | Moffitt Cancer Center Support Grant | 3 | 2025 |
| T32HL129982 | The Genetic Epidemiology of Heart, Lung, and Blood Traits Training Grant (GenHLB) | 3 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 3 | 2025 |
| UL1TR001881 | UCLA Clinical and Translational Science Institute | 3 | 2025 |
1 to 10 of 1,130Source NIH's project files
See all 1,130 nih grantsPapers1,462
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Spatial transcriptomic profiling of porcine tissue microarray detecting subclinical circovirus infection. | Front Vet Sci | 2026 | 42824453 | PubTator, text mining | PubMed |
| Diagnostic Overshadowing in Lennox-Gastaut Syndrome: Immerslund-Gräsbeck Syndrome Unmasked by Radiosurgical Stress. | J Child Neurol | 2026 | 42669795 | PubTator, text mining | PubMed |
| Case Report: Imerslund Grasbeck syndrome: a rare cause of megaloblastic anemia in a well-nourished child. | Front Nutr | 2026 | 42661605 | PubTator, text mining | PubMed |
| A Pilot Study of Urinary Cubilin Shedding in Type 1 Diabetes Mellitus: A Potential Biomarker to Predict Nephropathy. | J Diabetes Res | 2026 | 42630017 | PubTator, text mining | PubMed |
| COPI Coatomer Regulates Several Steps of HDL Metabolism. | Arterioscler Thromb Vasc Biol | 2026 | 42592650 | PubTator, text mining | PubMed |
| Genetic mutation patterns in Indonesian children with primary steroid-resistant nephrotic syndrome. | Pediatr Nephrol | 2026 | 42420527 | PubTator, text mining | PubMed |
| Immunometabolic Stratification of Autism Spectrum Disorder by CD4+ T-Cell Phenotype Reveals Subtype-Specific Energetic Deficit and Coordinated Suppression of Micronutrient Acquisition Pathways. | Metabolites | 2026 | 42346396 | PubTator, text mining | PubMed |
| Mapping metabolic reprogramming dynamics across pancreatic neuroendocrine tumor cell differentiation at single-cell transcriptomic resolution. | Front Genet | 2026 | 42338981 | PubTator, text mining | PubMed |
| Vitamin D as a cellular endocrine system: Tissue-specific microcircuits, immune reprogramming, and metabolic resistance. | iScience | 2026 | 42291276 | PubTator, text mining | PubMed |
| CUBN-AMN pathway loss in chronic benign proteinuria. | Kidney Int | 2026 | 42233899 | PubTator, text mining | PubMed |
1 to 10 of 1,462
See all 1,462 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/8029
GET https://conductscience.org/api/genes/v1/8029/patents?page=2